HRTX compared with EDSA: revenue, margins and what each company keeps, and the suppliers and customers both name

HRTXHeron Therapeutics, Inc.

Mkt capRevenueRevenue

EDSAEdesa Biotech, Inc.

Mkt capRevenueRevenue

Compare

HRTXHeron Therapeutics, Inc.

EDSAEdesa Biotech, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

HRTX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±62.0%▼−31.74%×0.51

May 11 '26±32.7%▼−21.05%×0.65

Q1 FY26±34.8%▲+11.11%×0.32

Q3 FY25±24.3%▼−3.39%×0.14

EDSA1 of 4 reports

Reportimpliedrealized× implied

Q3 FY26—▼−1.47%—

= impliedHRTX realized, solidEDSA realized, hatchedOne scale, both sides: full bar = 63%× = |realized| ÷ impliedSource: market data

HRTXHeron Therapeutics, Inc.

0.29▲+4.32%· post 0.29

Mkt cap$55.6MRevenue$38MQ2 FY26Revenue$155MFY25

EDSAEdesa Biotech, Inc.

2.19▲+2.82%· post 2.19

ClosedNov 6 '26

Mkt cap$20.6MRevenue—Revenue—

Compare

ClosedNov 6 '26

HRTXHeron Therapeutics, Inc.

EDSAEdesa Biotech, Inc.

0.29▲+4.32%post 0.29

Price

2.19▲+2.82%post 2.19

$55.6M

Mkt cap

$20.6M

Q2 FY26$38M

Revenue

—

FY25$155M

Revenue

—

HRTX0.29▲+4.32%vsEDSA2.19▲+2.82%ClosedNov 6 '26